Abstract
Monoclonal antibodies (MAbs) have been developed against a wide variety of tumor-associated antigens and normal tissue antigens, including receptor molecules, extracellular matrix proteins, enzymes, and hormones. The in vitro use of these MAbs has greatly improved our ability to diagnose a number of diseases, including many cancers. The extension of MAbs to in vivo diagnosis and therapy, as the “magic bullets” envisioned by Paul Ehrlich1 at the turn of the century, has, however, met with more limited success. There are a number of reasons for this, and currently there is a great effort underway, using animal models to solve these problems, to pave the way for clinical use of MAbs in patients. To illustrate the problems inherent in the development of radiolabeled MAbs for clinical use, we will present our work utilizing MAbs in a variety of brain tumor models.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
P. Ehrlich, Collected Studies on Immunology, Wiley, New York (1906).
J. L. Murray and L. M. Axtell, Impact of cancer: years of life lost due to cancer mortality, J. Natl. Cancer Inst. 52:3 (1974).
D. D. Bigner, Biology of gliomas: potential clinical implications of glioma cellular heterogeneity, Neurosurgery 9:320 (1981).
D. Stavrou, Monoclonal antibodies in neuro-oncology, Neurosurg. Rev. 13:7 (1991).
R. Virchow, Die krankhalten Geschwuelste, A. Hirshwald, Berlin, (11).
W. F. Bale and I. L. Spar, Studies directed toward the use of antibodies as carriers of radioactivity for therapy, Adv. Biol. Med. Phys. 5:285 (1957).
D. Pressman, E. D. Day, and M. Blau, The use of paired labeling in the determination of tumor-localizing antibodies, Cancer Res. 17:845 (1957).
V. Moshakis, R. A. J. McIlhinney, D. Raghaven, and A. M. Neville, Localization of human tumor xenografts after i.v. administration of radiolabeled monoclonal antibodies, Br. J. Cancer 44:91 (1981).
D. R. Groothuis, P. Molnar, and R. G. Blasberg, Regional blood flow and blood-to-tissue transport in five brain tumor models, Prog. Exp. Tumor Res. 27:132 (1984).
M. A. Bourdon, C. J. Wikstrand, H. Furthmayer, T. J. Matthews, and D. D. Bigner, Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody, Cancer Res. 43:2796 (1983).
M. A. Bourdon, R. E. Coleman, R. G. Blasberg, D. R. Groothuis, and Bigner, D.D., Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired label and imaging analysis, Anticancer Res. 4:133 (1984).
D. E. Bullard, C. J. Adams, R. E. Coleman, and D. D. Bigner, In vivo imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies, J. Neurosurg. 64:257 (1986).
Y. S. Lee, D. E. Bullard, M. R. Zalutsky, R. E. Coleman, H. S. Friedman, E. V. Colapinto, and D. D. Bigner, Therapeutic efficacy of murine monoclonal antibody 81C6 in a human glioma xenograft model, Cancer Res. 48:559 (1988).
Y. S. Lee, D. E. Bullard, P. A. Humphrey, E. V. Colapinto, H. S. Friedman, M. R. Zalutsky, R. E. Coleman, and D. D. Bigner, Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6, Cancer Res. 48:2904 (1988).
E. V. Colapinto, Y. S. Lee, P. A. Humphrey, M. R. Zalutsky, H. S. Friedman, D. E. Bullard, and D. D. Bigner, The localisation of radiolabelled murine monoclonal antibody 81C6 and its Fab fragment in human glioma xenografts in athymic mice, Br. J. Neurosurg. 2:173–186 (1988).
S. Carrel, R. S. Acolla, A. L. Carmagnola, and J. P. Mach, Common human melanoma associated antigen(s) detected by monoclonal antibodies, Cancer Res. 40:2523 (1980).
S. Carrel, M. Schreyer, A. Schmidt-Kessen, and J. P. Mach, Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines, Hybridoma 1:387 (1982).
E. V. Colapinto, P. A. Humphrey, M. R. Zalutsky, D. R. Groothuis, H. S. Friedman, N. de Tribolet, S. Carrel, and D. D. Bigner, Comparative localization of murine monoclonal antibody Mel-14 F(ab’)2 fragment and whole IgG2a in human glioma xenografts, Cancer Res. 48:5701 (1988).
E. V. Colapinto, M. R. Zalutsky, G. E. Archer, M. A. Noska, H. S. Friedman, S. Carrel, and D. D. Bigner, Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab’)2 fragments of monoclonal antibody Mel-14, Cancer Res. 50:1822 (1990).
D. Colcher, J. Esteban, J. A. Carrasquillo, P. Sugarbaker, J. C. Reynolds, G. Bryant, S. M. Larson, and J. Schlom, Comparison of route of administration of radiolabeled monoclonal antibodies in patients with colorectal cancer, J. Nucl. Med. 27:(Abst) 902 (1986).
W. B. Nelp, J. F. Eary, R. F. Jones, K. E. Hellstrom, I. Hellstrom, P. L. Beaumier, and K. A. Krohn, Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma, J. Nucl. Med. 28:34 (1987).
Y. S. Lee, D. E. Bullard, C. J. Wikstrand, M. R. Zalutsky, L. H. Muhlbaier, and D. D. Bigner, Comparison of monoclonal antibody delivery to intracranial glioma xenografts by intravenous and intracarotid administration, Cancer Res. 47:1941 (1987).
M. R. Zalutsky, R. P. Moseley, J. C. Benjamin, E. V. Colapinto, G. N. Fuller, H. P. Coakham, and D. D. Bigner, Monoclonal antibody and F(ab’)2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration, Cancer Res. 50:4105 (1990).
R. Moseley, M. R. Zalutsky, H. B. Coakham, R. E. Coleman, and D. D. Bigner, Distribution of 131I-8lC6 monoclonal antibody (MAb) administered via carotid artery in patients with glioma, J. Nucl. Med. 28:603-604 (1987).
H. J. G. Bloom, Medulloblastoma in children: increasing survival rates and further prospects, Int. J. Radiat. Oncol. Biol. Phys. 8:2023 (1982).
W. R. Wasserstrom, J. P. Glass, and J. B. Posner, Diagnosis and treatment of leptomeningeal metastases from solid tumors, Cancer 49:759 (1982).
H. E. Fuchs, G. E. Archer, O. M. Colvin, S. H. Bigner, J. M. Schuster, G. N. Fuller, L. H. Muhlbaier, S. C. Schold, H. S. Friedman, and D. D. Bigner, Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis, Cancer Res. 50:1954 (1990).
M. R. Zalutsky, P. K. Garg, J. M. Schuster, H. E. Fuchs, G. E. Archer, S. Garg, and D. D. Bigner, Radioimmunotherapy of leptomeningeal tumor using AT-211 monoclonal antibody. 9th International Congress of Radiation Research. Radiat. Res., in press (1991).
L. S. Lashford, A. G. Davies, R. B. Richardson, S. P. Bourne, J. A. Bullimore, H. Eckert, J. T. Kemshead, and H. B. Coakham, A pilot study of 131I monoclonal antibodies in the therapy of leptomeningeal tumors, Cancer 61:857 (1988).
R. P. Moseley, A. B. Davies, R. B. Richardson, M. Zalutsky, S. Carrel, J. Fabre, N. Slack, J. Bullimore, B. Pizer, V. Papanastassiou, J. T. Kemshead, H. B. Coakham, and L. S. Lashford, Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis, Br. J. Cancer 62:637 (1990).
P. A. Humphrey, A. J. Wong, B. Vogelstein, M. R. Zalutsky, G. N. Fuller, G. E. Archer, H. S. Friedman, M. M. Kwatra, S. H. Bigner, and D. D. Bigner, Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma, Proc. Natl. Acad. Sci. USA, 87:4207 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fuchs, H.E., Zalutsky, M.R., Archer, G.E., Bigner, D.D. (1991). Diagnosis and Therapy of Brain Tumors Utilizing Radiolabeled Monoclonal Antibodies. In: Kelly, J.W., Baldwin, T.O. (eds) Applications of Enzyme Biotechnology. Industry-University Cooperative Chemistry Program Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9235-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9235-5_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9237-9
Online ISBN: 978-1-4757-9235-5
eBook Packages: Springer Book Archive